Page 3 - Divi's Laboratories

Divi's Lab standalone Q3 net up 9% at Rs 268 crore

Income from operations uo 14% to Rs 976 cr; however, nine-month profit is flat at Rs 792 cr

Divi's Labs standalone Q3 net up 9% at Rs 268 cr

Total income from operations rose 13.5% to Rs 976.48 crore during the quarter

Divi's shares partly recover from the recent lows

After steep hit in two trading sessions, shares recovered with a 3.08% increase at Rs 788.9

One-third of Divi's scrip value melts down in two sessions

Possible import alert after USFDA remarks about firm's Vizag unit drags stock down to two-year low

Divi's scrip falls 21% on FDA remarks

USFDA observed that its Vizag facility was not maintained to ensure the quality of the APIs

Analysts caution against bottom fishing in Divi's

Strong observations by US FDA for Unit II facility, accounts for 70% of the company's revenues

Divi's Lab to shift Rs 500 cr project if Kakinada protest not resolved

Andhra Pradesh government had allotted 500 acres of land to the company near Kakinada in East Godavari district

Divi's Laboratories falls as Vizag unit gets five observations from USFDA

The stock dipped 6% to Rs 1,091 after USFDA has issued form 483 with five observations against its unit at Visakhapatnam of Andhra Pradesh.

Divi's Lab Q4 standalone net up 40% to Rs 322 crore

Total income up 34% to Rs 1,095 cr; full-year consolidated net up 31% to Rs 1,112 cr